Biomarker study of early death in patients with intermediate and favorable risk metastatic renal cell carcinoma.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.6_suppl.530
Abstract: 530Background: The primary objective of this study was to determine whether severe systemic inflammation (SSI) could serve as a biomarker for terminal disease progression and early death in patients with intermediate and favorable risk metastatic… read more here.
Keywords: intermediate favorable; death; death patients; favorable risk ... See more keywords